Amber Therapeutics, an innovative medical technology company developing a breakthrough implantable therapy to treat women with urinary incontinence, has taken over 7,000 sq. ft of space in Harwell’s new Tech Foundry development to build a new HQ for its R&D, manufacturing and production capabilities.
The company was founded in 2021 with core backing from Oxford Science Enterprises (OSE) and was recently named by Bloomberg as one of the top 25 Euro-startups to watch. Last year Amber Therapeutics raised a landmark $100m Series A financing round from leading healthcare and technology investors in the US and UK. The raise was one of the largest ever Series A rounds for a European medical technology company.
Amber Co-founder and CEO, Aidan Crawley said, “The Amber team is delighted to be relocating to Harwell. Our new HQ will become the only manufacturer and producer of Class III active implantable devices in the UK and we believe this site will be an absolute state of the art R&D facility that can fuel the development not just of our initial Amber UI therapy but the pipeline of ideas that our platform capability has in store.”
David Williams, Commercial Director at Harwell Campus said: “We’re delighted to welcome Amber Therapeutics to Harwell. We designed Tech Foundry to provide flexible, sustainable space for fast growing, highly technical companies. It’s the ideal space for Amber to scale their operations and advance their world-leading technology in our thriving health tech cluster.”
Harwell Campus is home to over 250 organisations spanning health tech, energy, space, and quantum. Amber Therapeutics’ move to the campus positions the company at the heart of a thriving health tech ecosystem, where it will sit alongside world-class national research facilities like Diamond Light Source and the MRC Mary Lyon Centre, and a vibrant health tech cluster of over 70 organisations including industry leaders such as Moderna and Oxford Nanopore.
The Tech Foundry development is the latest addition to the Campus’ 600 initiative, which will see a further 600,000 sq. ft of innovation and collaboration space built at the campus over the next couple of years.
